- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04758377
Characterizing Hemorrhage in Acute Spinal Cord Injury With MRI (CHASM)
The study is designed to determine whether hemorrhage within the injured spinal cord is influenced by mean arterial pressure (MAP) augmentation with vasopressors and by venous thromboembolism (VTE) prophylaxis with anticoagulants in the first two weeks following a traumatic spinal cord injury (tSCI).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This will be a single-center prospective observational study of patients with an acute cervical traumatic spinal cord injury
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada
- Vancouver General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Acute tSCI injury involving bony spinal levels between C0 and T1
- Baseline Asia Impairment Scale (AIS) grade of A, B, or C
- Admission to study site within 24 hours of injury
- Male or female age 19 or older
- Able and willing to provide informed consent
Exclusion Criteria:
- Pathological fracture due to metabolic condition or neoplasia
- Spinal cord injury due to infection
- Presence of pacemaker, aneurysm clip or other device which is a contraindication to MRI
- BMI > 40 and unable to fit within the MRI scanner
- Multiple life threatening injuries (ISS >16) that make transport to MRI not in the patient's best interest
- Any condition that, at the time of admission, prevents a complete ISNCSCI assessment from being performed
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm 1
Serial MRI scans of patients with acute cervical SCI to quantify hemorrhage. |
Serial MRI scans of patients with acute cervical SCI to quantify hemorrhage. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemorrhage Quantification 1
Time Frame: Serial MRI assessments: Injury to 2 weeks post injury
|
Area of hematoma |
Serial MRI assessments: Injury to 2 weeks post injury
|
|
Hemorrhage Quantification 2
Time Frame: Serial MRI assessments: Injury to 2 weeks post injury
|
Vertical length of hematoma and vertical length of cord edema |
Serial MRI assessments: Injury to 2 weeks post injury
|
|
Hemorrhage Quantification 3
Time Frame: Serial MRI assessments: Injury to 2 weeks post injury
|
The point of maximum cord compression vertebral level and anatomic point of maximum cord compression vertebral sublevel |
Serial MRI assessments: Injury to 2 weeks post injury
|
|
Hemorrhage Quantification 4
Time Frame: Serial MRI assessments: Injury to 2 weeks post injury
|
Vertical length of cord edema rostral to maximum compression and vertical length of cord edema caudal to maximum compression. |
Serial MRI assessments: Injury to 2 weeks post injury
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemodynamic Management Assessment 1
Time Frame: Injury to 2 weeks post injury
|
achieved mean arterial pressure |
Injury to 2 weeks post injury
|
|
Hemodynamic Management Assessment 2
Time Frame: Injury to 2 weeks post injury
|
vasopressor usage/dose |
Injury to 2 weeks post injury
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neurologic Assessments
Time Frame: Injury to 6 months post injury
|
International Standards for Neurological Classification of SCI (ISNCSCI) |
Injury to 6 months post injury
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Brian Kwon, MD, University of British Columbia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H20-03585
- CDMRP-SC190120 (Other Grant/Funding Number: CDMRP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.